BRISLYN SAYLOR: Open Payments
NPI 1689156747 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 39 payments from 8 companies in 2025. Trend: 2023 $15 · 2024 $30 · 2025 $1,230
Food & beverage: $1,131Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $442 |
| Regeneron Healthcare Solutions, Inc. | 7 | $251 |
| Novartis Pharmaceuticals Corporation | 14 | $181 |
| GENZYME CORPORATION | 2 | $148 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Greer Laboratories, Inc. | 2 | $53 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $18 |
Products named: DUPIXENT, FASENRA, TEZSPIRE, NUCALA, XOLAIR, ORALAIR, Rhapsido, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
